project id: TCGA-UCEC; case submitter id: TCGA-H5-A2HR; source center: 23; state: released; a260 a280 ratio: 1.81; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.7; rna integrity number: 8.7; age at index: 71; days to birth: -25986; ethnicity: not hispanic or latino; gender: female; race: black or african american; vital status: Alive; year of birth: 1935; age at diagnosis: 25986; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 53.0; figo stage: Stage IB; icd 10 code: C54.1; last known disease status: not reported; morphology: 8380/3; primary diagnosis: Endometrioid adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Endometrium; synchronous malignancy: No; tissue or organ of origin: Endometrium; tumor grade: Not Reported; year of diagnosis: 2006; treatment or therapy: not reported; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1627; days to sample procurement: 0; initial weight: 110.0; portion submitter id: TCGA-H5-A2HR-01A-11; percent lymphocyte infiltration: 20.0; percent monocyte infiltration: 0.0; percent necrosis: 20.0; percent neutrophil infiltration: 10.0; percent normal cells: 0.0; percent stromal cells: 10.0; percent tumor cells: 70.0; percent tumor nuclei: 90.0;